Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Outcomes Study to Measure Reduction in Pain and Numbness During Administration of an Amino Acid Formulation in Subjects Diagnosed With Peripheral Neuropathy

NCT01537705 is registered in ClinicalTrials.gov with Targeted Medical Pharma as lead sponsor.

NCT NCT01537705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01537705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Outcomes Study to Measure Reduction in Pain and Numbness During Administration of an Amino Acid Formulation in Subjects Diagnosed With Peripheral Neuropathy
Lead sponsor
Targeted Medical Pharma
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2012
Completion date
July 31, 2012
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy induced neuropathy, diabetic neuropathy, hiv neuropathy, trauma induced neuropathy